9
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T74762 |
Influenza A virus-IN-8
|
||
Influenza A virus-IN-8 (S5) 为一种大环肽,无细胞毒性,并作为甲型流感病毒 (IAV) 的有效抑制剂,显示出较好的蛋白酶稳定性。其对 H1 和 H5 变体的IC50值分别低至 6.7 nM 和 6.6 nM。此外,Influenza A virus-IN-8 能够与 HA 茎的一个保守区域结合,特别是对 H1 变体展现出 1.0 nM 的高亲和性Kd 值。 | |||
TP1822L |
CEF6 acetate(913545-15-0 free base)
|
Influenza Virus | Microbiology/Virology |
CEF6 acetate(913545-15-0 free base) 是 HLA-B7限制性流感病毒核蛋白表位,属于 CEF 对照肽。 CEF 对照肽长度为 8-12 个氨基酸,其序列来自人类巨细胞病毒、爱泼斯坦-巴尔病毒和流感病毒。 | |||
T26873 |
BMY-27709
BMY 27709,BMY27709 |
Influenza Virus | Microbiology/Virology |
BMY-27709 是一种流感病毒生长抑制剂,对 A/WSN/33 病毒生长的 IC50 值为 3-8 μM,对流感病毒的部分亚型也展现出抑制活性。BMY-27709 对 H1 和 H2 病毒感染的早期起作用,通过抑制血凝素蛋白展现其抗病毒活性。然而,BMY-27709 对 H3 亚型病毒以及 B 型/Lee/40 流感病毒没有作用。 | |||
TP1822 |
CEF6
|
||
CEF6, a HLA-B7 restricted influenza virus nucleoprotein epitope, belongs to the CEF control peptides. The CEF control peptides are 8-12 amino acids in length, with sequences derived from the human cytomegalovirus, Epstein-Barr virus and influenza virus. | |||
T10677 |
Carbodine
|
Others | Others |
Carbodine (Carbocyclic cytidine) is a broad-spectrum antiviral agent and targets CTP synthetase that converts UTP to CTP. It possesses significant antiviral activity against influenza virus types A0/PR-8/34 and A2/Aichi/2/68 in vitro. | |||
T38340 |
10-Norparvulenone
|
||
10-Norparvulenone is a fungal metabolite originally isolated fromMicrosphaeropsis.1It decreases viral sialidase activity in, and increases survival of, MDCK cells infected with the mouse-adapted influenza virus A/PR/8/34 when used at a concentration of 1 μg/ml. 1.Fukami, A., Nakamura, T., Kim, Y.P., et al.A new anti-influenza virus antibiotic, 10-norparvulenone from Microsphaeropsis sp. FO-5050J. Antibiot. (Tokyo)53(10)1215-1218(2000) | |||
T27983 |
MBX2546
MBX-2546,MBX 2546 |
||
MBX2546 is an Influenza A Virus Fusion Inhibitor. MBX2546 binds to HA and inhibits HA-mediated membrane fusion. Both binding and stabilization of HA by MBX2546 are required for the inhibition of viral infection. Mutations in MBX2546-resistant influenza A/ | |||
T38008 | KBC-007 | ||
KBC-007 is a synthetic branched chain-containing analog of α-galactosylceramide (α-GalCer). It induces IL-4 and IFN-γ secretion by mouse splenocytes when used at a concentration of 0.5 ng/ml and IL-2 secretion by DN32.D3 NKT hybridoma cells co-cultured with CD1d-transfected RBL cells pre-loaded with KBC-007 at a concentration of 8 ng/ml. KBC-007 (1 μg per animal) increases levels of IL-4, but not IFN-γ, to a similar degree as α-GalCer in mouse serum. KBC-007 (0.5 μg per animal) increases the sur... | |||
T62812 | RdRP-IN-4 | ||
RdRP-IN-4 (compound 11q) 是一种芳基苯甲酰肼类似物,是一种口服具有活力的甲型流感病毒 RNA 依赖性 RNA 聚合酶 (RdRp) 抑制剂,能够直接结合 RdRp 的 PB1 亚基。RdRP-IN-4 可有效抑制 H5N1 禽流感病毒株,在 MDCK 细胞的 EC50=18 nM。RdRP-IN-4 对 H1N1 (A/PR/8/34) Flu A 株和 Flu B 株 (B/Lee/1940) 具有抑制作用,其 EC50 值分别为 53 nM 和 20 nM。RdRP-IN-4 以剂量依赖性方式显著抑制病毒核蛋白 (NP) 的表达水平。RdRP-IN-4 在受感染的小鼠中具有明显的抗病毒作用。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1347 |
8-Prenylkaempferol
去甲脱水淫羊藿黄素 |
p38 MAPK; NF-κB; PI3K | MAPK; NF-κB; PI3K/Akt/mTOR signaling |
8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and |